10x Insights
Loading account…
Companies / Healthcare / KEWAUNEE SCIENTIFIC CORP
KEQU

KEWAUNEE SCIENTIFIC CORP

HealthcareMedical Instruments
Ticker KEQUSTATESVILLE, NCFiscal year ends AprilBook value per share $25.68Diluted shares 2.9M

Kewaunee Scientific Corporation (NASDAQ: KEQU) is a recognized leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture and infrastructure products. The company was founded in 1906 and has been publicly traded since 1968. Its website is www.kewaunee.com. From the company’s description.

Fiscal year 2026 · ends 04-30Changes are against fiscal 2025The amber dot is the latest twelve months, to 2026-07-31
Sales & profitability
$282.00M
+17.3% year over year
Last 12 mo $277.22M
5.93%
−1.5 percentage points
Last 12 mo 5.43%
$10.46M
−9.7% year over year
Last 12 mo $9.15M
12.87%
−4.8 percentage points
Last 12 mo 10.97%
Cash & financing
$18.63M
+26.0% year over year
Last 12 mo $14.82M
$14.70M
+16.5% year over year
Last 12 mo $10.88M
0.61
Was 1.00× a year earlier
Last 12 mo 0.60
3.0M
+0.1% year over year
Last 12 mo 2.9M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What KEWAUNEE SCIENTIFIC CORP does

In the company’s own words

Kewaunee Scientific Corporation (NASDAQ: KEQU) is a recognized leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture and infrastructure products. The company was founded in 1906 and has been publicly traded since 1968. Its website is www.kewaunee.com.

The company's core product portfolio includes steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. In November 2024, Kewaunee completed the acquisition of Nu Aire, Inc., a manufacturer of biological safety cabinets, CO2 incubators, ultralow freezers, animal handling equipment, pharmacy compounding isolators, and related laboratory products. This acquisition significantly expanded the company's capabilities and product offerings, allowing it to serve a broader range of laboratory and healthcare customers.

The company operates through two reportable segments: the Lab Products Group, which includes operations in Statesville, North Carolina and the Nu Aire subsidiary in Plymouth, Minnesota, and the International segment, consisting of foreign subsidiaries. During fiscal year 2026, approximately 28 percent of revenues were derived from international sales.

Kewaunee maintains manufacturing facilities in Statesville and Long Lake, Minnesota, as well as in Bangalore, India. The company employs 755 domestic employees and 476 international employees as of April 30, 2026. Sales offices are located in the United States, Spain, India, Saudi Arabia, and Singapore. Products are sold primarily to pharmaceutical, biotechnology, industrial, chemical and commercial research laboratories, educational institutions, healthcare institutions, governmental entities, and manufacturing facilities through direct customer relationships, dealers, subsidiaries, and a national distributor.

The company's business model involves designing and manufacturing customized products for building construction projects, often with extended delivery timelines. Prices are typically quoted on a firm basis, requiring the company to manage material and labor cost increases between quotation and delivery. The order backlog at April 30, 2026 was $165.9 million, with an estimated 90 percent expected to ship during fiscal year 2027.

Company details
Sector
Healthcare
Industry
Medical Instruments
Headquarters
STATESVILLE, NC
Fiscal year end
April
CIK
55529
SIC
3821

Financial performance, year by year

Fiscal 2014–2026 · USD
$-34.80M$51.60M$138.00M$224.40M$310.80M2014201520162017201820192020202120222023202420252026Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns KEWAUNEE SCIENTIFIC CORP — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

46
funds hold it
0 of 35
superinvestors hold it
$15.21M
held by funds, at market
14.2%
of shares held by funds

Largest fund holders · KEWAUNEE SCIENTIFIC CORP’s weight in each

VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
0.37%of fund net assets
U.S. SMALL CAP VALUE PORTFOLIO
DFSVX · DFA INVESTMENT DIMENSIONS GROUP INC
0.01%of fund net assets
Avantis U.S. Small Cap Value ETF
AVUV · American Century ETF Trust
0.01%of fund net assets
VANGUARD EXTENDED MARKET INDEX FUND
VXF · VANGUARD INDEX FUNDS
0.00%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do KEWAUNEE SCIENTIFIC CORP and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of KEWAUNEE SCIENTIFIC CORP's earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in KEWAUNEE SCIENTIFIC CORP's last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.